Skip to main content
OpenTrials
Completed

NCT Number: NCT04236375

Eye Movement and Cognitive Dysfunction

There is association between eye movement disorder and cognitive dysfunction. Therefore, utilizing eye movement and screening for cognitive dysfunction is feasible. In the present study, the investigators will develop an artificial intelligence platform to screening for cognitive dysfunction by inspecting the function of eye movement. Futher more, based on the screening results, the platform will offer referral suggestions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Eye Movement Disorder Central Nervous System Diseases Cognition Disorders Cognitive Dysfunction Cranial Nerve Diseases Eye Diseases Mental Disorders Nervous System Diseases Neurocognitive Disorders Ocular Motility Disorders

Age range

45 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ①Subjects who are diagnosed as mild cognitive decline, Alzheimer's disease, Vascular dementia, Lewy body dementia, Frontotemporal dementia, other dementia and normal by neurologist.
  • ②Subjects who can cooperate with the inspection.
  • ③Subjects who agree to participate in the study and sign the consent form

Exclusion criteria

  • ①Subjects who cannot do the inspection.
  • ②Subjects who suffer from diseases that compromise the inspection.

Treatment and study plan

Primary outcomes

  1. Area under the curve

    Time frame: up to 1 month

    AUC values for predicting whether subject has cognitive impairment or not

Secondary outcomes

  1. Accuracy, true positive rate, and true negetive rate

    Time frame: up to 1 month

    The performance of this artificial platform

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Registry information

Official study title

The Development of an Artificial Intelligence Platform for Screening and Referral of Cognitive Dysfunction

Acronym: EMCD

Important dates

Study start
2020
Primary completion
2025
Study completion
2025
First posted
Jan 22, 2020
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.